SBFM - Sunshine Biopharma acquires Nora Pharma for C$30M
- Sunshine Biopharma ( NASDAQ: SBFM ) said on Thursday it had completed the acquisition of all the outstanding shares of Nora Pharma for C$30M ($21.9M).
- The acquisition will help Sunshine Biopharma to expand its operations into the area of generic prescription drugs and biosimilars.
- Nora Pharma currently offers over 50 pharmaceutical products, including generic prescription drugs, over-the-counter products and biosimilars.
- Nora Pharma will operate as a subsidiary of Sunshine.
- ( SBFM ) is down ~4% premarket.
For further details see:
Sunshine Biopharma acquires Nora Pharma for C$30M